Immediate Impact

4 from Science/Nature 59 standout
Sub-graph 1 of 24

Citing Papers

Fibroblast and myofibroblast activation in normal tissue repair and fibrosis
2024 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
4 intermediate papers

Works of David Barron being referenced

Identifying HER2 mutation, amplification, and HER2 protein overexpression as therapeutic targets in lung cancers.
2016
RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation
2014

Author Peers

Author Last Decade Papers Cites
David Barron 214 225 25 140 13 550
Natasha Musrap 276 152 19 161 14 595
Harunori Nakashima 272 297 12 114 15 580
Allen Saliganan 257 199 36 270 14 591
Claudia Ligorio 284 252 18 270 11 612
Stéphanie Brayer 291 243 13 107 9 549
Jennifer A. Markovics 179 198 15 96 11 587
Xinhai Wan 233 183 27 205 10 495
Roberto Verardo 193 178 6 211 16 528
Lambert J. C. M. Van den Broek 170 194 46 123 14 537
Maria Chiara Anania 255 171 12 138 15 547

All Works

Loading papers...

Rankless by CCL
2026